Th1, Th2 and Th17 cytokine profile in patients with multiple sclerosis following treatment with rapamycin
IJI-Iranian Journal of Immunology. 2016; 13 (2): 141-147
en Inglés
| IMEMR
| ID: emr-183929
ABSTRACT
Background:
Management of multiple sclerosis [MS] is based on the usage of immunosuppressive and immune-modulating medications. Cytokines play an important role in the pathogenesis of MS
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Iran. J. Immunol.
Año:
2016
Similares
MEDLINE
...
LILACS
LIS